The Automated Screening Working Groups is a group of software engineers and biologists passionate about improving scientific manuscripts on a large scale. Our members have created tools that check for common problems in scientific manuscripts, including information needed to improve transparency and reproducibility. We have combined our tools into a single pipeline, called ScreenIT. We're currently using our tools to screen COVID preprints.

About Followers

Latest preprint reviews

  1. Proxalutamide Improves Inflammatory, Immunologic, and Thrombogenic Markers in Mild-to-Moderate COVID-19 Males and Females: an Exploratory Analysis of a Randomized, Double-Blinded, Placebo-Controlled Trial Early Antiandrogen Therapy (EAT) with Proxalutamide (The EAT-Proxa Biochemical AndroCoV-Trial)

    1. Flávio Adsuara Cadegiani
    2. Andy Goren
    3. Carlos Gustavo Wambier
    4. Ricardo Ariel Zimerman

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Agent-based modelling of reactive vaccination of workplaces and schools against COVID-19

    1. Benjamin Faucher
    2. Rania Assab
    3. Jonathan Roux
    4. Daniel Levy-Bruhl
    5. Cécile Tran Kiem
    6. Simon Cauchemez
    7. Laura Zanetti
    8. Vittoria Colizza
    9. Pierre-Yves Boëlle
    10. Chiara Poletto

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Predicting Managers' Mental Health Across Countries: Using Country-Level COVID-19 Statistics

    1. Lun Li
    2. Stephen X. Zhang
    3. Lorenz Graf-Vlachy

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Safety and efficacy of COVID-19 hyperimmune globulin (HIG) solution in the treatment of active COVID-19 infection- Findings from a Prospective, Randomized, Controlled, Multi-Centric Trial

    1. Devang Parikh
    2. Alok Chaturvedi
    3. Naman Shah
    4. Piyush Patel
    5. Ronak Patel
    6. Suma Ray

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Altered pre-existing SARS-CoV-2-specific T cell responses in elderly individuals

    1. Naoyuki Taira
    2. Sakura Toguchi
    3. Mio Miyagi
    4. Tomoari Mori
    5. Hiroaki Tomori
    6. Koichi Oshiro
    7. Osamu Tamai
    8. Mitsuo Kina
    9. Masatake Miyagi
    10. Kentaro Tamaki
    11. Mary K Collins
    12. Hiroki Ishikawa

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. SARS-CoV-2 in the Republic of Guinea: Fragment and Whole-Genome Sequencing, Phylogenetic Analysis

    1. A.A. Kritsky
    2. Ya.M. Krasnov
    3. M. Keita
    4. S. Keita
    5. A.V. Fedorov
    6. A.P. Shevtsova
    7. N.P. Guseva
    8. E.V. Kazorina
    9. E.A. Sosedova
    10. A.D. Katyshev
    11. E.A. Naryshkina
    12. E.V. Kolomoets
    13. S.A. Shcherbakova
    14. A.Yu. Popova
    15. V.V. Kutyrev

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Clinico-histopathologic and single-nuclei RNA-sequencing insights into cardiac injury and microthrombi in critical COVID-19

    1. Michael I. Brener
    2. Michelle L. Hulke
    3. Nobuaki Fukuma
    4. Stephanie Golob
    5. Robert S. Zilinyi
    6. Zhipeng Zhou
    7. Christos Tzimas
    8. Ilaria Russo
    9. Claire McGroder
    10. Ryan D. Pfeiffer
    11. Alexander Chong
    12. Geping Zhang
    13. Daniel Burkhoff
    14. Martin B. Leon
    15. Mathew S. Maurer
    16. Jeffrey W. Moses
    17. Anne-Catrin Uhlemann
    18. Hanina Hibshoosh
    19. Nir Uriel
    20. Matthias J. Szabolcs
    21. Björn Redfors
    22. Charles C. Marboe
    23. Matthew R. Baldwin
    24. Nathan R. Tucker
    25. Emily J. Tsai

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistance

    1. Izumi Kimura
    2. Yusuke Kosugi
    3. Jiaqi Wu
    4. Jiri Zahradnik
    5. Daichi Yamasoba
    6. Erika P. Butlertanaka
    7. Yuri L. Tanaka
    8. Keiya Uriu
    9. Yafei Liu
    10. Nanami Morizako
    11. Kotaro Shirakawa
    12. Yasuhiro Kazuma
    13. Ryosuke Nomura
    14. Yoshihito Horisawa
    15. Kenzo Tokunaga
    16. Takamasa Ueno
    17. Akifumi Takaori-Kondo
    18. Gideon Schreiber
    19. Hisashi Arase
    20. Chihiro Motozono
    21. Akatsuki Saito
    22. So Nakagawa
    23. Kei Sato

    Reviewed by Rapid Reviews Infectious Diseases, ScreenIT

    3 evaluationsAppears in 2 listsLatest version Latest activity

  9. Unrestricted Online Sharing of High-frequency, High-resolution Data on SARS-CoV-2 in Wastewater to Inform the COVID-19 Public Health Response in Greater Tempe, Arizona

    1. Devin A. Bowes
    2. Erin M. Driver
    3. Simona Kraberger
    4. Rafaela S. Fontenele
    5. LaRinda A. Holland
    6. Jillian Wright
    7. Bridger Johnston
    8. Sonja Savic
    9. Melanie Engstrom Newell
    10. Sangeet Adhikari
    11. Rahul Kumar
    12. Hanah Goetz
    13. Allison Binsfeld
    14. Kaxandra Nessi
    15. Payton Watkins
    16. Akhil Mahant
    17. Jake Zevitz
    18. Stephanie Deitrick
    19. Philip Brown
    20. Richard Dalton
    21. Chris Garcia
    22. Rosa Inchausti
    23. Wydale Holmes
    24. Xiao-Jun Tian
    25. Arvind Varsani
    26. Efrem S. Lim
    27. Matthew Scotch
    28. Rolf U. Halden

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Tolerability, safety and immunogenicity of intradermal delivery of a fractional dose mRNA-1273 SARS-CoV-2 vaccine in healthy adults as a dose sparing strategy

    1. Geert V.T. Roozen
    2. Margaretha L.M. Prins
    3. Rob van Binnendijk
    4. Gerco den Hartog
    5. Vincent P. Kuiper
    6. Corine Prins
    7. Jacqueline J. Janse
    8. Annelieke C. Kruithof
    9. Mariet C.W. Feltkamp
    10. Marjan Kuijer
    11. Frits R. Rosendaal
    12. Meta Roestenberg
    13. Leo G. Visser
    14. Anna H.E. Roukens

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Newer Page 1045 of 2361 Older